Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

FRAX1036

FRAX1036 is a PAK inhibitor with Kis of 23.3 nM, 72.4 nM, and 2.4 μM for PAK1, PAK2 and PAK4, respectively.

Product Specifications

CAS Number

[1432908-05-8]

UNSPSC

12352005

Hazard Statement

H302-H315-H319-H335

Target

PAK

Type

Reference compound

Related Pathways

Cell Cycle/DNA Damage; Cytoskeleton

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/FRAX1036.html

Purity

99.49

Solubility

DMSO : 5.3 mg/mL (warming)

Smiles

O=C1C(C2=CC=C(C3=NC(C)=CN=C3)C=C2Cl)=CC4=CN=C(NCCC5CCN(C)CC5)N=C4N1CC

Molecular Formula

C28H32ClN7O

Molecular Weight

518.05

Precautions

P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501

References & Citations

[1]Ong CC, et al. Small molecule inhibition of group I p21-activated kinases in breast cancer induces apoptosis and potentiates the activity of microtubule stabilizing agents. Breast Cancer Res. 2015 Apr 23;17:59.|[2]Mortazavi F, et al. Significance of KRAS/PAK1/Crk pathway in non-small cell lung cancer oncogenesis. BMC Cancer. 2015 May 9;15:381.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Isoform

PAK1; PAK2; PAK4

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Cytokeratin 6 (CK6A, CK6B, CK6C, CK6D, CK6E, Keratin Type II Cytoskeletal 6A, Keratin Type II Cytoskeletal 6B, Keratin Type II Cytoskeletal 6C, Keratin Type II Cytoskeletal 6D, Keratin Type II Cytoskeletal 6E, KRT6, KRT6A, KRT6B, KRT6C, KRT6D, KRT6E) (AP)
MBS6123016-01 0.1 mL

Cytokeratin 6 (CK6A, CK6B, CK6C, CK6D, CK6E, Keratin Type II Cytoskeletal 6A, Keratin Type II Cytoskeletal 6B, Keratin Type II Cytoskeletal 6C, Keratin Type II Cytoskeletal 6D, Keratin Type II Cytoskeletal 6E, KRT6, KRT6A, KRT6B, KRT6C, KRT6D, KRT6E) (AP)

Ask
View Details
Cytokeratin 6 (CK6A, CK6B, CK6C, CK6D, CK6E, Keratin Type II Cytoskeletal 6A, Keratin Type II Cytoskeletal 6B, Keratin Type II Cytoskeletal 6C, Keratin Type II Cytoskeletal 6D, Keratin Type II Cytoskeletal 6E, KRT6, KRT6A, KRT6B, KRT6C, KRT6D, KRT6E) (AP)
MBS6123016-02 5x 0.1 mL

Cytokeratin 6 (CK6A, CK6B, CK6C, CK6D, CK6E, Keratin Type II Cytoskeletal 6A, Keratin Type II Cytoskeletal 6B, Keratin Type II Cytoskeletal 6C, Keratin Type II Cytoskeletal 6D, Keratin Type II Cytoskeletal 6E, KRT6, KRT6A, KRT6B, KRT6C, KRT6D, KRT6E) (AP)

Ask
View Details
Taar1 (NM_134328) Rat Tagged ORF Clone Lentiviral Particle
RR203080L3V 200 µL

Taar1 (NM_134328) Rat Tagged ORF Clone Lentiviral Particle

Ask
View Details
JPH1 Antibody
A68362-50UG 50 µg

JPH1 Antibody

Ask
View Details
1-Ethynylcyclopentanol
sc-224673 5 g

1-Ethynylcyclopentanol

Ask
View Details
Lentiviral human KLRC4 shRNA (UAS) - Lentiviral human KLRC4 shRNA (UAS) (100)
GTR15093102 1 Vial

Lentiviral human KLRC4 shRNA (UAS) - Lentiviral human KLRC4 shRNA (UAS) (100)

Ask
View Details